A549
|
IC50 |
|
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 23819871]
|
A549
|
IC50 |
13.45 μM
Compound: Oridonin
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
|
[PMID: 31494472]
|
A549
|
IC50 |
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 31202992]
|
A549
|
IC50 |
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 30921757]
|
A549
|
IC50 |
|
Antiproliferative activity against human A549 cells incubated for 72 hrs by CCK8 cells
Antiproliferative activity against human A549 cells incubated for 72 hrs by CCK8 cells
|
[PMID: 31200238]
|
Bel-7402
|
IC50 |
|
Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay
Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay
|
[PMID: 28165738]
|
Bel-7402
|
IC50 |
|
Antiproliferative activity against human Bel7402 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human Bel7402 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 30921757]
|
Bel-7402
|
IC50 |
|
Antiproliferative activity against human Bel7402 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human Bel7402 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 31202992]
|
Bel-7402
|
IC50 |
9.59 μM
Compound: Oridonin
|
Antiproliferative activity against human Bel7402 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Antiproliferative activity against human Bel7402 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 30981113]
|
BEL-7404 tumor cell line
|
IC50 |
|
Antiproliferative activity against human Bel7404 cells after 48 hrs by MTT assay
Antiproliferative activity against human Bel7404 cells after 48 hrs by MTT assay
|
[PMID: 28165738]
|
DU-4475
|
IC50 |
|
Antiproliferative activity against human DU4475 cells after 72 hrs by MTT assay
Antiproliferative activity against human DU4475 cells after 72 hrs by MTT assay
|
[PMID: 32610904]
|
H22
|
IC50 |
|
Antiproliferative activity against mouse H22 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against mouse H22 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 35121201]
|
HCC1806
|
IC50 |
|
Antiproliferative activity against human HCC1806 cells after 72 hrs by MTT assay
Antiproliferative activity against human HCC1806 cells after 72 hrs by MTT assay
|
[PMID: 32610904]
|
HCC1937
|
IC50 |
|
Antiproliferative activity against human HCC1937 cells after 72 hrs by MTT assay
Antiproliferative activity against human HCC1937 cells after 72 hrs by MTT assay
|
[PMID: 32610904]
|
HCT-116
|
IC50 |
6.84 μM
Compound: Oridonin
|
Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 30981113]
|
HeLa
|
IC50 |
|
Antiproliferative activity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 35121201]
|
HepG2
|
IC50 |
|
Antiproliferative activity against human HepG2 cells incubated for 72 hrs by CCK8 cells
Antiproliferative activity against human HepG2 cells incubated for 72 hrs by CCK8 cells
|
[PMID: 31200238]
|
HL-60
|
IC50 |
|
Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
|
[PMID: 23819871]
|
HL-60
|
IC50 |
|
Antiproliferative activity against human HL60 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human HL60 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 30921757]
|
K562
|
IC50 |
|
Antiproliferative activity against human K562 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human K562 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 35121201]
|
K562
|
IC50 |
|
Antiproliferative activity against human K562 cells after 72 hrs by MTT assay
Antiproliferative activity against human K562 cells after 72 hrs by MTT assay
|
[PMID: 28165738]
|
K562
|
IC50 |
|
Antiproliferative activity against human K562 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human K562 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 30921757]
|
K562
|
IC50 |
|
Antiproliferative activity against human K562 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human K562 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 31202992]
|
KB 3-1
|
IC50 |
|
Antiproliferative activity against human KB-3-1 cells after 48 hrs by MTT assay
Antiproliferative activity against human KB-3-1 cells after 48 hrs by MTT assay
|
[PMID: 28165738]
|
L02
|
IC50 |
17.47 μM
Compound: 1; ORI
|
Cytotoxicity against human LO2 cells incubated for 72 hrs by CCK8 cells
Cytotoxicity against human LO2 cells incubated for 72 hrs by CCK8 cells
|
[PMID: 31200238]
|
L02
|
IC50 |
|
Cytotoxicity against human L02 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human L02 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 31202992]
|
L02
|
IC50 |
|
Cytotoxicity against human L02 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human L02 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 30921757]
|
L02
|
IC50 |
|
Cytotoxicity against human L02 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human L02 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 35121201]
|
L02
|
IC50 |
42.25 μM
Compound: Oridonin
|
Cytotoxicity against human L02 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay
Cytotoxicity against human L02 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay
|
[PMID: 35428012]
|
L02
|
IC50 |
6.97 μM
Compound: Oridonin
|
Cytotoxicity in human L02 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity in human L02 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 30981113]
|
MCF7
|
IC50 |
|
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 23819871]
|
MCF7
|
IC50 |
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 35121201]
|
MCF7
|
IC50 |
17.56 μM
Compound: Oridonin
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 30981113]
|
MCF7
|
IC50 |
|
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 28165738]
|
MCF7
|
IC50 |
21.97 μM
Compound: Oridonin
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
|
[PMID: 31494472]
|
MCF7
|
IC50 |
|
Antiproliferative activity against ER-positive human MCF7 cells after 48 hrs by MTT assay
Antiproliferative activity against ER-positive human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 35033884]
|
MDA-MB-231
|
IC50 |
|
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 35121201]
|
MDA-MB-231
|
IC50 |
|
Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by MTT assay
|
[PMID: 32610904]
|
MDA-MB-231
|
EC50 |
29.4 μM
Compound: Oridonin
|
Antiproliferative activity against human MDA-MB-231 cells incubated for 48 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells incubated for 48 hrs by MTT assay
|
[PMID: 30981113]
|
MDA-MB-453
|
IC50 |
|
Antiproliferative activity against human MDA-MB-453 cells after 72 hrs by MTT assay
Antiproliferative activity against human MDA-MB-453 cells after 72 hrs by MTT assay
|
[PMID: 32610904]
|
MDA-MB-468
|
IC50 |
|
Antiproliferative activity against human MDA-MB-468 cells after 72 hrs by MTT assay
Antiproliferative activity against human MDA-MB-468 cells after 72 hrs by MTT assay
|
[PMID: 32610904]
|
MGC-803
|
IC50 |
14.13 μM
Compound: Oridonin
|
Antiproliferative activity against human MGC803 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
Antiproliferative activity against human MGC803 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
|
[PMID: 31494472]
|
MGC-803
|
IC50 |
|
Antiproliferative activity against human MGC-803 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human MGC-803 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 35121201]
|
MGC-803
|
IC50 |
|
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
|
[PMID: 28165738]
|
NCI/ADR-RES
|
IC50 |
|
Antiproliferative activity against human MCF7/ADR cells after 72 hrs by MTT assay
Antiproliferative activity against human MCF7/ADR cells after 72 hrs by MTT assay
|
[PMID: 32610904]
|
NCI-H460
|
IC50 |
|
Antiproliferative activity against human NCI-H460 cells after 48 hrs by MTT assay
Antiproliferative activity against human NCI-H460 cells after 48 hrs by MTT assay
|
[PMID: 28165738]
|
PBMC
|
IC50 |
|
Cytotoxicity against human PBMC assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human PBMC assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 31202992]
|
PC-3
|
IC50 |
|
Antiproliferative activity against human PC3 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human PC3 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 30921757]
|
PLC-PRF-5
|
IC50 |
|
Antiproliferative activity against human PLC/PRF/5 cells incubated for 72 hrs by CCK8 cells
Antiproliferative activity against human PLC/PRF/5 cells incubated for 72 hrs by CCK8 cells
|
[PMID: 31200238]
|
RAW264.7
|
IC50 |
|
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 18 hrs by Griess method
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 18 hrs by Griess method
|
[PMID: 23819871]
|
RPMI-8226
|
IC50 |
|
Antiproliferative activity against human RPMI8226 cells incubated for 72 hrs by CCK8 cells
Antiproliferative activity against human RPMI8226 cells incubated for 72 hrs by CCK8 cells
|
[PMID: 31200238]
|
SGC-7901
|
IC50 |
|
Antiproliferative activity against human SGC7901 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human SGC7901 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 30921757]
|
SGC-7901
|
IC50 |
|
Antiproliferative activity against human SGC7901 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human SGC7901 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 31202992]
|
SK-BR-3
|
IC50 |
|
Antiproliferative activity against human SK-BR-3 cells after 72 hrs by MTT assay
Antiproliferative activity against human SK-BR-3 cells after 72 hrs by MTT assay
|
[PMID: 32610904]
|
SMMC-7721
|
IC50 |
|
Cytotoxicity against human SMMC7721 cells after 48 hrs by MTT assay
Cytotoxicity against human SMMC7721 cells after 48 hrs by MTT assay
|
[PMID: 23819871]
|
SMMC-7721
|
IC50 |
|
Antiproliferative activity against human SMMC-7221 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human SMMC-7221 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 35121201]
|
SW480
|
IC50 |
|
Cytotoxicity against human SW480 cells after 48 hrs by MTT assay
Cytotoxicity against human SW480 cells after 48 hrs by MTT assay
|
[PMID: 23819871]
|
SW480
|
IC50 |
|
Antiproliferative activity against human SW480 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human SW480 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 35121201]
|
T47D
|
IC50 |
|
Antiproliferative activity against human T47D cells after 72 hrs by MTT assay
Antiproliferative activity against human T47D cells after 72 hrs by MTT assay
|
[PMID: 32610904]
|
TE-1
|
IC50 |
12.73 μM
Compound: Oridonin
|
Antiproliferative activity against human TE1 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
Antiproliferative activity against human TE1 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
|
[PMID: 31494472]
|
U-87MG ATCC
|
IC50 |
|
Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 35121201]
|